Ubs Group Ag Protara Therapeutics, Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Protara Therapeutics, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 7,418 shares of TARA stock, worth $43,840. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,418

Holding current value

$43,840

% of portfolio

0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1.7 - $2.4 $12,610 - $17,803	7,418 New	7,418 $13,000
Q1 2024 May 13, 2024	BUY	$1.86 - $4.83 $5,224 - $13,567	2,809 Added 306.66%	3,725 $14,000
Q4 2023 Feb 09, 2024	BUY	$1.12 - $1.93 $890 - $1,534	795 Added 657.02%	916 $1,000
Q3 2023 Nov 09, 2023	BUY	$1.64 - $2.93 $198 - $354	121 New	121 $0
Q1 2023 May 12, 2023	SELL	$2.76 - $3.91 $3,668 - $5,196	-1,329 Reduced 57.78%	971 $3,000
Q4 2022 Feb 08, 2023	BUY	$2.43 - $3.7 $5,008 - $7,625	2,061 Added 862.34%	2,300 $6,000
Q3 2022 Nov 10, 2022	SELL	$2.96 - $4.27 $3,054 - $4,406	-1,032 Reduced 81.2%	239 $1,000
Q2 2022 Aug 10, 2022	BUY	$2.8 - $5.33 $1,951 - $3,715	697 Added 121.43%	1,271 $4,000
Q1 2022 May 16, 2022	BUY	$4.19 - $6.9 $2,405 - $3,960	574 New	574 $3,000
Q3 2021 Nov 15, 2021	SELL	$6.38 - $9.3 $631 - $920	-99 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$8.68 - $16.99 $11,613 - $22,732	-1,338 Reduced 93.11%	99 $1,000
Q1 2021 May 12, 2021	BUY	$13.75 - $23.86 $10,670 - $18,515	776 Added 117.4%	1,437 $23,000
Q4 2020 Feb 11, 2021	BUY	$16.97 - $25.34 $8,875 - $13,252	523 Added 378.99%	661 $16,000
Q3 2020 Nov 12, 2020	SELL	$16.76 - $31.89 $8,916 - $16,965	-532 Reduced 79.4%	138 $2,000
Q2 2020 Jul 31, 2020	BUY	$22.0 - $60.7 $14,740 - $40,669	670 New	670 $20,000

Others Institutions Holding TARA

# of Institutions

Shares Held

10.7M

Call Options Held

Put Options Held

1.8K

Ra Capital Management, L.P. Boston, MA

1.9M
Shares

$11.2 Million
0.05% of portfolio
Opaleye Management Inc. Boston, MA

1.68M
Shares

$9.94 Million
0.56% of portfolio
Stem Point Capital LP New York, NY

943K
Shares

$5.57 Million
0.52% of portfolio
Woodline Partners LP San Francisco, CA

852K
Shares

$5.03 Million
0.01% of portfolio
Boxer Capital, LLC San Diego, CA

812K
Shares

$4.8 Million
0.08% of portfolio

View Full List

About Protara Therapeutics, Inc.

Ticker TARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,267,400
Market Cap $66.6M
Description
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...

More about TARA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account